Sustained complete remission of a limited-stage blastic plasmacytoid dendritic cell neoplasm followed by a simultaneous combination of low-dose DeVIC therapy and radiation therapy: A case report and review of the literature

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2603-2608

  Sugimoto, Kei Ji ^a   Shimada, Asami ^a   Yamaguchi, Nanae ^a   Imai, Hidenori ^a   Wakabayashi, Mutsumi ^a   Sekiguchi, Yasunobu ^a   Izumi, Hiroshi ^a   Ota, Yasunori ^c   Komatsu, Norio ^b   Noguchi, Masaaki ^a  

^a JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Blastic plasmacytoid dendritic cell neoplasm; CD123; CD4; CD56; DeVIC; Local radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD4 ANTIGEN; DEXAMETHASONE; ETOPOSIDE; IFOSFAMIDE; TUMOR MARKER;

ADJUVANT CHEMORADIOTHERAPY; AGED; ARTICLE; BIOPSY; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CANCER STAGING; CASE REPORT; CD123; CD56; CHEMISTRY; DENDRITIC CELL; DEVIC; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; LOCAL RADIATION THERAPY; MALE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIATION EXPOSURE; REMISSION; SKIN TUMOR; TIME; TREATMENT OUTCOME; WHOLE BODY IMAGING;

BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; CD123; CD4; CD56; DEVIC; LOCAL RADIATION THERAPY;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARBOPLATIN; CHEMORADIOTHERAPY, ADJUVANT; DENDRITIC CELLS; DEXAMETHASONE; ETOPOSIDE; HUMANS; IFOSFAMIDE; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; REMISSION INDUCTION; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; WHOLE BODY IMAGING;

EID: 84887037079     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Facchetti F, Jones DM and Petrella T. Blastic plasmacytoid dendritic cell neoplasm. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France:International Agency for Research on Cancer (IARC), 2008.
2. Garnache-Ottou F, Feuillard J, Ferrand C, Biichle S, Trimoreau F, Seilles E, Salaun V, Garand R, Lepelley P, Maynadie M, Kuhlein E, Deconinck E, Daliphard S, Chaperot L, Beseggio L, Foisseaud V, Macintyre E, Bene MC, Saas P, Jacob MC;GOELAMS and GEIL study. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia. Br J Haematol 2009;145:624-636.
3. Petrella T, Meijer CJ, Dalac S, Willemze R, Maynadie M, Machet L, Casasnovas O, Vergier B and Teitell MA. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis. Am J Clin Pathol 2004;122:307-313.
4. Bekkenk MW, Jansen PM, Meijer CJ and Willemze R. CD56+ hematological neoplasms presenting in the skin:a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004;15:1097-1108.
5. Okamoto M, Maruyama F, Tsuzuki M, Nomura T, Miyazaki H, Wakita M, Kojima H, Sobue R, Matsui T and Ino T. [Salvage chemotherapy for relapsed/refractory aggressive non-Hodgkin's lymphoma with a combination of dexamethasone, etoposide, ifosfamide and carboplatin]. Rinsho Ketsueki 1994;35:635-641.
6. Yamaguchi M, Tobinai K, Oguchi M, Ishizuka N, Kobayashi Y, Isobe Y, Ishizawa K, Maseki N, Itoh K, Usui N, Wasada I, Kinoshita T, Ohshima K, Matsuno Y, Terauchi T, Nawano S, Ishikura S, Kagami Y, Hotta T and Oshimi K. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymph-oma:Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol 2009;27:5594-5600.
7. Kwong YL, Kim WS, Lim ST, Kim SJ, Tang T, Tse E, Leung AY and Chim CS. SMILE for natural killer/T-cell lymphoma:analysis of safety and efficacy from the Asia Lymphoma Study Group. Blood 2012;120:2973-2980.
8. Ascani S, Massone C, Ferrara G, Rongioletti F, Papini M, Pileri S and Cerroni L. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases. J Cutan Pathol 2008;35:911-915.
9. Fontaine J, Thomas L, Balme B, Ronger-Savle S, Traulle C, Petrella T and Dalle S. Haematodermic CD4+CD56+ neoplasm:complete remission after methotrexate-asparaginase treatment. Clin Exp Dermatol 2009;34:e43-45.
10. Dalle S, Beylot-Barry M, Bagot M, Lipsker D, Machet L, Joly P, Dompmartin A, d'Incan M, Maubec E, Grange F, Dereure O, Prey S, Barete S, Wetterwald M, Fraitag S and Petrella T. Blastic plasmacytoid dendritic cell neoplasm:is transplantation the treatment of choice? Br J Dermatol 2010;162:74-79.